title: Radiotherapy combined with erythropoietin for the treatment of extramedullary hematopoiesis in an alloimmunized patient with thalassemia intermedia.
abstract: We report a patient with thalassemia intermedia who developed a mediastinal syndrome due to the growth of paravertebral hematopoietic masses in the posterior mediastinum. Because the patient did not receive blood transfusions due to alloimmunization, she was first treated with human recombinant erythropoietin (escalating low-moderate doses) to recover hemoglobin levels, then in association with radiotherapy to prevent a worsening of her anemia. The mean Hb level dramatically increased and peaked at week 11, to 83 g/l, and remained unchanged before and after radiotherapy (81 versus 78 g/l). Immediately after radiotherapy extramedullary hematopoiesis volume decreased by 16.4%.
authors.affiliation: Ospedale S. Eugenio, Cattedra di Ematologia, Universita Tor Vergata, Centro Microcitemie, Rome, Italy.
authors.forename: P
authors.initials: P
authors.lastname: Cianciulli
authors.forename: F
authors.initials: F
authors.lastname: Sorrentino
authors.forename: L
authors.initials: L
authors.lastname: Morino
authors.forename: A
authors.initials: A
authors.lastname: Massa
authors.forename: G L
authors.initials: GL
authors.lastname: Sergiacomi
authors.forename: V
authors.initials: V
authors.lastname: Donato
authors.forename: S
authors.initials: S
authors.lastname: Amadori
mesh_terms: D000328:Adult; D004921:Erythropoietin / Q000627:therapeutic use*; D005260:Female; D006411:Hematopoiesis, Extramedullary / Q000528:radiation effects*; D006801:Humans; D007518:Isoantibodies / Q000032:analysis*; D011878:Radiotherapy; D011994:Recombinant Proteins; D013789:Thalassemia / Q000503:physiopathology* / Q000532:radiotherapy / Q000628:therapy*
chemical_list: D007518:Isoantibodies; D011994:Recombinant Proteins; D004921:Erythropoietin